Q3 2022 G1 Therapeutics Inc Earnings Call Transcript
Hello, and thank you for standing by. Welcome to the G1 Therapeutics Third Quarter 2022 Financial Results Conference Call. (Operator Instructions)
I would now like to hand the conference over to your opening speaker Vice President of Communications; Will Roberts. Will, please proceed.
Thank you, Sheena. Good morning, everyone, and welcome to the G1 conference held to discuss our third quarter '22 financial results and business update. The press release on these financial results was issued this morning and can be found on the News section of our corporate website, g1therapeutics.com. On this morning's call, the team will provide a business overview of the third quarter of '22, including an update on our clinical programs and our commercial progress in that period with COSELA, which is approved and commercially available to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum etoposide containing regimen
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |